Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-07-09, Stock:ABBV, The news for the past five days is as follows:
2018-06-29: NEWS1: Abbvie, Androgel partner owe $488 million in antitrust case: U.S. judge.NEWS2: Lilly's (LLY) Taltz Positive in Ankylosing Spondylitis Study.NEWS3: Lilly's (LLY) Taltz Positive in Ankylosing Spondylitis Study.NEWS4: Vertex Pops As Rival Disappoints In Cystic Fibrosis And AbbVie Opts Out.NEWS5: Vertex Pharma Jumps 14% After Rival Releases Poor Cystic Fibrosis Drug Results.NEWS6: Why Vertex Pharmaceuticals Incorporated Stock Surged 14% Today.NEWS7: Why Vertex Pharmaceuticals Incorporated Stock Surged 14% Today.NEWS8: Why Vertex Pharmaceuticals Incorporated Stock Surged 14% Today.NEWS9: XLV, UNH, MRK, ABBV: Large Outflows Detected at ETF.NEWS10: XLV, UNH, MRK, ABBV: Large Outflows Detected at ETF.NEWS11: Galapagos: Silver Lining to Disappointing Study Data.NEWS12: Bad News Delivers a Decisive Blow to Galapagos N.V..NEWS13: Will a Trade War With China Wreak Havoc in US Healthcare?.NEWS14: Will a Trade War With China Wreak Havoc in US Healthcare?.NEWS15: Should Value Investors Consider AbbVie (ABBV) Stock Now?.NEWS16: Benzinga's Daily Biotech Pulse: Gemphire On Fire, Acceleron-Celgene Taste Success, AbbVie Ditches Galapagos.NEWS17: Biotech Stocks Facing FDA Decision In July.NEWS18: Biotech Stocks Facing FDA Decision In July.
2018-07-02: NEWS1: AbbVie Is Out-Trading Its Value — Why It Could Still Be Worth More.NEWS2: Health Care Sector Update for 07/02/2018: SNNA,MRNS,ABBV,PRGO,TEVA,NVS,ADMP.NEWS3: Health Care Sector Update for 07/02/2018: SNNA,MRNS,ABBV,PRGO,TEVA,NVS,ADMP.NEWS4: Health Care Sector Update for 07/02/2018: ABBV,PRGO,TEVA,NVS,ADMP,MRK,AZN.NEWS5: Health Care Sector Update for 07/02/2018: ABBV,PRGO,TEVA,NVS,ADMP,MRK,AZN.NEWS6: Gilead's (GILD) CAR T Therapy Gets Positive CHMP Opinion.NEWS7: Gilead's (GILD) CAR T Therapy Gets Positive CHMP Opinion.NEWS8: Vertex's Shares Rally as a Rival's CF Candidate Disappoints.NEWS9: Vertex's Shares Rally as a Rival's CF Candidate Disappoints.NEWS10: Vertex&apos;s Shares Rally as a Rival&apos;s CF Candidate Disappoints.NEWS11: 7 Favorite Picks of a $40 Billion Portfolio Star.
2018-07-03: NEWS1: Is Pfizer's Price Hike an Effect of Drug Policy on Sector?.NEWS2: Is Pfizer's Price Hike an Effect of Drug Policy on Sector?.NEWS3: AstraZeneca's Two New Cancer Drugs Get Approval in Japan.NEWS4: AstraZeneca's Two New Cancer Drugs Get Approval in Japan.NEWS5: Insiders Bullish on Certain Holdings of DIVB.NEWS6: Insiders Bullish on Certain Holdings of DIVB.NEWS7: AstraZeneca&apos;s Two New Cancer Drugs Get Approval in Japan.NEWS8: 5 Great Dividend Growth Stocks to Counter Volatility.NEWS9: The 5 Biggest Blockbuster Drugs of 2024, and the Companies Poised to Profit From Them.
2018-07-05: NEWS1: AbbVie wins reversal of $140 mln verdict in case over AndroGel risks.NEWS2: U.S. judge tosses $140 mln verdict against AbbVie in AndroGel case.NEWS3: Here's Why AbbVie Stock is Good for Your Portfolio's Health.NEWS4: Here's Why AbbVie Stock is Good for Your Portfolio's Health.NEWS5: A Look At Biotech In 2018 And The Biggest Catalysts Coming Up In The Second Half Of The Year.NEWS6: Here&apos;s Why AbbVie Stock is Good for Your Portfolio&apos;s Health.NEWS7: If You Like Dividends, You Should Love These 3 Stocks.NEWS8: If You Like Dividends, You Should Love These 3 Stocks.NEWS9: [$$] AbbVie Director Makes Biggest-Ever Insider Stock Buy.NEWS10: FOCUS-Drugmakers try evasion, tougher negotiations to fight new U.S. insurer tactic.NEWS11: If You Like Dividends, You Should Love These 3 Stocks.
2018-07-06: NEWS1: 3 Buy-Rated Large Cap Pharma Stocks to Boost Health in July.NEWS2: 3 Buy-Rated Large Cap Pharma Stocks to Boost Health in July.NEWS3: How Does Biogen Make its Money?.NEWS4: Bristol-Myers' Sprycel Gets EC Approval for Label Expansion.NEWS5: Bristol-Myers' Sprycel Gets EC Approval for Label Expansion.NEWS6: 3 Buy-Rated Large Cap Pharma Stocks to Boost Health in July.

Answer: Rise